Similar results were obtained with SCID mice challenged with the CD19+ human Burkitt’s lymphoma cell line Ramos treated with 3 doses of BU12-SAP IT starting at day + 7 from tumor cell injection [18]. The gene discussed is CD19; the disease is Burkitt lymphoma.